Arvinas, Inc. announced that Kelly Page has joined the company as Senior Vice President, Global Head of Oncology Strategy and Program Leadership. Ms. Page has over 25 years of global pharmaceutical industry experience from the research setting through global commercialization, with nearly 20 years of experience in oncology therapeutics. She recently served as Vice President, Head of Global Commercial, Hematology at AstraZeneca, where she was responsible for ensuring the successful commercialization of CALQUENCE®, with functional responsibility for commercial strategy and marketing across the hematology portfolio.

Ms. Page has also held leadership positions of increasing responsibility at companies including Takeda Oncology and Pfizer.